The simple reason is pharma wants to develop chronic use drugs or cancer drugs, and why would they want to make antibiotics that are carefully rationed, if prof

The simple reason is pharma wants to develop chronic use drugs or cancer drugs, and why would they want to make antibiotics that are carefully rationed, if profits are lower? Seems to me, we may need a socialized, international effort, an ISS of antibiotic development.